Diginex Limited closed its acquisition of The Remedy Project Limited on January 8, 2026, issuing 1 million ordinary shares to the Remedy Project’s sole shareholder and agreeing to issue up to an additional 1 million shares if operating and earn‑out targets are met over the next three years. The Remedy Project, a Hong Kong‑based advisory and research firm founded in 2020, specializes in labor and human‑rights due diligence across global supply chains.
The deal brings The Remedy Project’s expertise in grievance mechanisms, capacity building and data‑driven insights into Diginex’s diginexLUMEN and diginexAPPRISE platforms. By integrating on‑the‑ground human‑rights expertise with AI‑powered risk analytics, Diginex positions itself to help clients meet the EU Corporate Sustainability Due Diligence Directive and to capture a larger share of the expanding ESG compliance market.
Diginex’s financial backdrop shows strong revenue growth but persistent losses. For the fiscal year ended March 31, 2025, revenue reached $2.0 million while the company posted a net loss of $5.2 million. In the six months ended September 30, 2025, revenue was again $2.0 million, with a net operating loss of $6.0 million. The company’s market capitalization was reported at $769 million around the time of the announcement, underscoring the scale of the transaction relative to its valuation.
Investor sentiment has remained cautious. Market participants have expressed concerns about Diginex’s ongoing unprofitability and the lack of recent earnings guidance, which has tempered enthusiasm for the acquisition despite its strategic fit. The company’s stock has traded below key moving averages, reinforcing a cautious outlook among investors.
CEO Mark Blick described the acquisition as a “pivotal step” in Diginex’s mission to empower businesses with actionable sustainability solutions, noting that the Remedy Project’s knowledge will amplify the impact of its supply‑chain platforms. Archana Kotecha, Founder and CEO of The Remedy Project, highlighted the opportunity to combine human‑rights expertise with technology at scale, bridging the gap between risk identification and outcome delivery.
The Remedy Project acquisition is part of a broader M&A strategy that includes agreements to acquire Plan A and Matter DK ApS. By consolidating complementary capabilities, Diginex aims to build a comprehensive ESG platform that can address regulatory demands and capture new revenue streams, while continuing to invest in growth initiatives that may delay short‑term profitability.
In summary, the acquisition strengthens Diginex’s end‑to‑end ESG offering and aligns the company with evolving regulatory requirements. However, the persistence of net losses and investor caution highlight the need for continued focus on profitability and execution risk as the company scales its integrated platform.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.